4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0000947871-16-001218
Director bought 1,712,400 shares at an average $10.42 ($17,849,568)
From the SEC's structured data for this filing
Trades in this filing
Thompson Peter A. · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-05-20 | Purchase : show line 1 in the form | +2,400 | $10.04 | $24,096 | 28,043,404 | I |
| 2016-05-23 | Purchase : show line 2 in the form | +1,191,600 | $10.40 | $12,392,640 | 29,235,004 | I |
| 2016-05-24 | Purchase : show line 3 in the form | +518,400 | $10.48 | $5,432,832 | 29,753,404 | I |
| Open-market purchases · 1,712,400 sh · avg $10.42 · $17,849,568 | ||||||
Loading xslF345X03/ss1486944_4.xml…